DNMT1 and neoplasm: In cancer cells, anti-proliferation/tumor suppressor genes are frequently silenced by promoter CpG methylation, which led to the pursuit of DNMT inhibitors (DNMTi) as potential cancer therapeutics to reactivate these genes and stop or even reverse tumor growth and cell invasiveness.